ARCHIVES

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Robert Day New AACI President, John Potter President Elect: Howard Appointment Near

June 21, 1985

ACS Elects New Volunteer Leaders

November 19, 2010

Mace Rothenberg Leaves Vanderbilt For Pfizer Oncology.

November 14, 2008

Bristol-Myers Awards 42.5 Million In Cancer Grants

October 21, 1977

In Brief: McDonnell Foundation Selects Five For Awards; James Benson Is Named Interim FDA Head

November 24, 1989

Letter From Congress Prompts NCI To Pull Abortion Fact Sheet From Web

July 12, 2002